Il y a eu 31 transactions d'initiés récentes enregistrées pour BioNTech SE (BNTX), dont 0 achats et 0 ventes.
Les initiés notables ayant une activité récente comprennent Poetting Sierk, Tureci Ozlem, Hanekamp Annemarie. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — BNTX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2029-05-28 |
Poetting Sierk |
Chief Operating Officer |
Inconnu |
8,838 |
- |
- |
- |
| 2029-05-28 |
Tureci Ozlem |
Chief Medical Officer |
Inconnu |
9,306 |
- |
- |
- |
| 2029-05-28 |
Hanekamp Annemarie |
Chief Commercial Officer |
Inconnu |
8,838 |
- |
- |
- |
| 2029-05-28 |
Ryan James Timothy Patrick |
See Remarks. |
Inconnu |
8,838 |
- |
- |
- |
| 2029-05-28 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Inconnu |
18,747 |
- |
- |
- |
| 2029-05-27 |
Poetting Sierk |
Chief Operating Officer |
Inconnu |
11,047 |
- |
- |
- |
| 2029-05-27 |
Tureci Ozlem |
Chief Medical Officer |
Inconnu |
11,633 |
- |
- |
- |
| 2029-05-27 |
Hanekamp Annemarie |
Chief Commercial Officer |
Inconnu |
11,047 |
- |
- |
- |
| 2029-05-27 |
Ryan James Timothy Patrick |
See Remarks. |
Inconnu |
11,047 |
- |
- |
- |
| 2029-05-27 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Inconnu |
23,434 |
- |
- |
- |
| 2027-12-08 |
Ryan James Timothy Patrick |
See Remarks. |
Inconnu |
750 |
- |
- |
- |
| 2027-05-22 |
Poetting Sierk |
Chief Operating Officer |
Inconnu |
18,416 |
$113.94 |
$2.1M |
- |
| 2027-05-22 |
Tureci Ozlem |
Chief Medical Officer |
Inconnu |
18,416 |
$113.94 |
$2.1M |
- |
| 2027-05-22 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Inconnu |
38,506 |
$113.94 |
$4.39M |
- |
| 2026-05-31 |
Poetting Sierk |
Chief Operating Officer |
Inconnu |
14,664 |
$152.10 |
$2.23M |
- |
| 2026-05-31 |
Tureci Ozlem |
Chief Medical Officer |
Inconnu |
14,664 |
$152.10 |
$2.23M |
- |
| 2026-05-31 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Inconnu |
19,997 |
$152.10 |
$3.04M |
- |
| 2026-03-18 |
Poetting Sierk |
Chief Operating Officer |
Inconnu |
- |
- |
- |
1,638 |
| 2026-03-18 |
Jeggle Helmut Wolfgang |
Director |
Inconnu |
- |
- |
- |
332,316 |
| 2026-03-18 |
Motschmann Michael |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-18 |
Wandschneider Ulrich |
Director |
Inconnu |
- |
- |
- |
1,927 |
| 2026-03-18 |
Ryan James Timothy Patrick |
See Remarks. |
Inconnu |
- |
- |
- |
4,795 |
| 2026-03-18 |
Jimenez Kylie |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-18 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Inconnu |
- |
- |
- |
858,209 |
| 2026-03-18 |
Zapata Gomez Ramon |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-18 |
Blackwood Nicola Claire |
Director |
Inconnu |
- |
- |
- |
- |
| 2026-03-18 |
Morawietz Anja |
Director |
Inconnu |
- |
- |
- |
40 |
| 2026-03-18 |
Staudigl Rudolf |
Director |
Inconnu |
- |
- |
- |
400 |
| 2025-05-12 |
Poetting Sierk |
Chief Operating Officer |
Inconnu |
7,112 |
$185.23 |
$1.32M |
- |
| 2025-05-12 |
Tureci Ozlem |
Chief Medical Officer |
Inconnu |
7,112 |
$185.23 |
$1.32M |
- |
| 2025-05-12 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Inconnu |
17,780 |
$185.23 |
$3.29M |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
